IL140550A - Methods for early diagnosis of carcinomas - Google Patents

Methods for early diagnosis of carcinomas

Info

Publication number
IL140550A
IL140550A IL14055099A IL14055099A IL140550A IL 140550 A IL140550 A IL 140550A IL 14055099 A IL14055099 A IL 14055099A IL 14055099 A IL14055099 A IL 14055099A IL 140550 A IL140550 A IL 140550A
Authority
IL
Israel
Prior art keywords
carcinomas
early diagnosis
methods
overexpression
cell cycle
Prior art date
Application number
IL14055099A
Other languages
English (en)
Other versions
IL140550A0 (en
Original Assignee
Magnus Von Knebel Doeberitz
Deutsches Krebsforsch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Magnus Von Knebel Doeberitz, Deutsches Krebsforsch filed Critical Magnus Von Knebel Doeberitz
Publication of IL140550A0 publication Critical patent/IL140550A0/xx
Publication of IL140550A publication Critical patent/IL140550A/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57411—Specifically defined cancers of cervix
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
IL14055099A 1998-07-01 1999-07-01 Methods for early diagnosis of carcinomas IL140550A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19829473A DE19829473C2 (de) 1998-07-01 1998-07-01 Verfahren zur frühen Diagnose von Carcinomen
PCT/DE1999/002094 WO2000001845A2 (de) 1998-07-01 1999-07-01 Verfahren zur frühen diagnose von carcinomen

Publications (2)

Publication Number Publication Date
IL140550A0 IL140550A0 (en) 2002-02-10
IL140550A true IL140550A (en) 2005-08-31

Family

ID=7872684

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14055099A IL140550A (en) 1998-07-01 1999-07-01 Methods for early diagnosis of carcinomas

Country Status (22)

Country Link
US (2) US6709832B1 (pl)
EP (1) EP1092155B1 (pl)
JP (1) JP3404020B2 (pl)
KR (1) KR100646193B1 (pl)
CN (1) CN1209627C (pl)
AT (1) ATE230487T1 (pl)
AU (1) AU749769B2 (pl)
BR (1) BRPI9912227B8 (pl)
CA (1) CA2336153C (pl)
CZ (1) CZ292076B6 (pl)
DE (2) DE19829473C2 (pl)
DK (1) DK1092155T3 (pl)
ES (1) ES2190820T3 (pl)
HU (1) HUP0102744A2 (pl)
IL (1) IL140550A (pl)
MX (1) MXPA00012852A (pl)
NO (1) NO328685B1 (pl)
PL (1) PL198623B1 (pl)
RU (1) RU2217761C2 (pl)
SK (1) SK284056B6 (pl)
TR (1) TR200003903T2 (pl)
WO (1) WO2000001845A2 (pl)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1388734B1 (en) * 2002-08-01 2004-03-03 MTM Laboratories AG Method for solution based diagnosis
US7306926B2 (en) * 1998-07-01 2007-12-11 Mtm Laboratories Ag Method for detecting carcinomas in a solubilized cervical body sample
AUPP991199A0 (en) * 1999-04-21 1999-05-13 University Of Sydney, The Methods for diagnosing pre-cancerous and cancerous conditions
DE10006033B4 (de) 2000-02-10 2005-11-10 Professor Dr. Magnus von Knebel Doeberitz Chirurgische Universitätsklinik Sektion für Molekulare Diagnostik und Therapie Immunisierung eines Individuums gegen Carcinome und ihre Vorstufen
US7408041B2 (en) 2000-12-08 2008-08-05 Alexion Pharmaceuticals, Inc. Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
US20060057651A1 (en) * 2000-12-08 2006-03-16 Bowdish Katherine S Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
US9249229B2 (en) 2000-12-08 2016-02-02 Alexion Pharmaceuticals, Inc. Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
AUPR201500A0 (en) * 2000-12-11 2001-01-11 Biosceptre Pty Ltd Methods for identifying pre-neoplastic and neoplastic states in mammals
DE10063179A1 (de) * 2000-12-18 2002-06-20 Bayer Ag Verfahren zur spezifischen Detektion von Tumorzellen und ihren Vorstufen in Gebärmutterhalsabstrichen durch simultane Messung von mindestens zwei verschiedenen molekularen Markern
EP1961767B1 (en) 2001-01-17 2012-03-07 Biosceptre International Limited Diagnosis and treatment of cancers and other conditions
EP1369694A1 (en) 2002-04-09 2003-12-10 MTM Laboratories AG Method for discrimination of metaplasias from neoplastic or preneoplastic lesions
EP1422526A1 (en) * 2002-10-28 2004-05-26 MTM Laboratories AG Method for improved diagnosis of dysplasias
US20050266409A1 (en) * 2003-02-04 2005-12-01 Wyeth Compositions and methods for diagnosing, preventing, and treating cancers
JP4317188B2 (ja) * 2003-02-26 2009-08-19 シスメックス株式会社 細胞の検査方法
ATE289685T1 (de) * 2003-08-25 2005-03-15 Mtm Lab Ag Verfahren zum nachweis von karzinomen in solubilisierten zervikalen körperproben
EP1756577B1 (en) * 2004-03-24 2012-03-14 Tripath Imaging, Inc. Methods and compositions for the detection of cervical disease
US8921057B2 (en) * 2004-05-31 2014-12-30 Sysmex Corporation Method of assessing properties of mammalian cells, and method of diagnosing cancer using the same
EP1628135A1 (en) * 2004-08-20 2006-02-22 MTM Laboratories AG Method for detecting medically relevant conditions in a solubilized LBC sample
US7892750B1 (en) * 2004-12-23 2011-02-22 University Of Notre Dame Du Lac Cathepsin E as a marker of colon cancer
JP4766969B2 (ja) 2005-09-14 2011-09-07 シスメックス株式会社 組織性質判定装置
US7972776B2 (en) * 2005-11-15 2011-07-05 Oncohealth Corporation Protein chips for HPV detection
KR20140091765A (ko) 2006-01-12 2014-07-22 알렉시온 파마슈티칼스, 인코포레이티드 Ｏｘ-2/ｃｄ200에 대한 항체 및 이들의 용도
US8067550B2 (en) * 2006-10-10 2011-11-29 Biosceptre International Limited Hybridomas producing antibodies against non functional P2X7 receptor
US8968995B2 (en) * 2008-11-12 2015-03-03 Oncohealth Corp. Detection, screening, and diagnosis of HPV-associated cancers
US8278056B2 (en) 2008-06-13 2012-10-02 Oncohealth Corp. Detection of early stages and late stages HPV infection
JP5111902B2 (ja) * 2007-03-14 2013-01-09 シスメックス株式会社 癌の診断支援装置
EP2028600B1 (en) 2007-08-24 2016-10-26 Sysmex Corporation Diagnosis support system for cancer, diagnosis support for information providing method for cancer, and computer program product
JP5670192B2 (ja) 2007-09-14 2015-02-18 バイオセプター・インターナショナル・リミテッド 新規ｐ２ｘ７エピトープ
US8293491B2 (en) 2007-09-14 2012-10-23 Biosceptre International Limited Purinergic (P2X) receptors in extra-cellular body fluid
AU2009266430B2 (en) 2008-07-04 2014-08-14 Biosceptre International Limited Anti- P2X7 peptides and epitopes
JP2012526286A (ja) * 2009-05-07 2012-10-25 オンコヘルス コーポレーション ヒトパピローマウイルス（ｈｐｖ）およびｈｐｖ関連癌の初期段階および後期段階の検出、スクリーニング、および診断のための高度または≧ｃｉｎ２の同定
JP5936067B2 (ja) 2009-08-20 2016-06-15 バイオセプター・（オーストラリア）・ピーティーワイ・リミテッド 抗ｐ２ｘ７受容体抗体およびその断片
EP2516470B1 (en) 2009-12-24 2018-02-07 Biosceptre (Aust) Pty Ltd Antibodies to non-functional oligomeric p2x7 receptors
CN102822672B (zh) 2010-01-08 2015-12-09 安科健康公司 用于诊断和筛选与hpv有关的癌症的高通量细胞基hpv免疫测定
US8900813B2 (en) 2010-08-17 2014-12-02 Medical Diagnostic Laboratories, Llc CIP2A as a biomarker in detection of cervical cancer
AU2011301153B2 (en) 2010-09-10 2014-11-27 Biosceptre International Limited Companion animal treatments
US9551700B2 (en) 2010-12-20 2017-01-24 Milagen, Inc. Device and methods for the detection of cervical disease
ES2689272T3 (es) 2011-07-01 2018-11-13 Biosceptre (Aust) Pty Ltd Terapia de combinación
US10527526B2 (en) 2011-11-03 2020-01-07 Tripath Imaging, Inc. Methods and compositions for preparing samples for immunostaining
BR112014011563B1 (pt) * 2011-11-15 2022-05-24 University Of Miami Método para determinar um risco aumentado de carcinoma de células escamosas de cabeça e pescoço (hnscc) em um indivíduo humano infectado com papiloma vírus humano (hpv), e kit
US11761963B2 (en) 2017-09-27 2023-09-19 Alexion Pharmaceuticals, Inc. Biomarker signature for predicting tumor response to anti-CD200 therapy
WO2019234176A1 (en) 2018-06-07 2019-12-12 Universitaet Des Saarlandes Novel biomarkers for carcinoma diagnosis
CN108893534A (zh) * 2018-06-26 2018-11-27 华中科技大学鄂州工业技术研究院 泛癌症诊断标记物
RU2707884C1 (ru) * 2018-10-03 2019-12-02 федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) (ФГАОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава России (Се Способ ранней диагностики почечно-клеточной карциномы по наличию антител к зрительному аррестину
FR3088640A1 (fr) 2018-10-14 2020-05-22 Smart Diagnostix Pharma Nouveau polypeptide se liant specifiquement a la proteine p16
CN111257565A (zh) * 2018-12-03 2020-06-09 上海细胞治疗集团有限公司 一种衰老细胞的检测试剂盒及其检测方法
CN113295683A (zh) * 2021-05-24 2021-08-24 烟台海关技术中心 过氧化苯甲酰检测方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281061A (en) * 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
US5268463A (en) * 1986-11-11 1993-12-07 Jefferson Richard A Plant promoter α-glucuronidase gene construct
ATE242806T1 (de) 1992-10-16 2003-06-15 Cold Spring Harbor Lab Umlagerung des cyclin komlexes und seine darauf bezogenen anwendungen
WO1994012881A2 (en) * 1992-12-02 1994-06-09 Hochstrasser Denis F A METHOD FOR DETECTING GROWING CELLS USING TRANSLATIONALLY CONTROLLED TUMOR PROTEIN p21
US5543291A (en) * 1993-01-29 1996-08-06 Dana Farber Cancer Institute Method of detecting carcinoma
US6316208B1 (en) * 1994-01-07 2001-11-13 Memorial Sloan-Kettering Cancer Center Methods for determining isolated p27 protein levels and uses thereof
RU2164419C2 (ru) * 1994-03-18 2001-03-27 Мириад Дженетикс, Инк. Ген mts, мутации данного гена и способы диагностики злокачественных опухолей с использованием последовательности гена mts
FI955416A7 (fi) * 1994-03-18 1996-01-09 Myriad Genetics Inc MTS-geenin sukusolulinjan mutaatioita ja menetelmä syövälle altistumis en löytämiseksi MTS-geenistä
US5763190A (en) * 1994-09-21 1998-06-09 The Trustees Of The University Of Pennsylvania Methods for the identification of compounds capable of inducing the nuclear translocation of a receptor complex comprising the glucocoticoid receptor type II and viral protein R interacting protein
US6033847A (en) * 1995-02-06 2000-03-07 St. Jude Children's Research Hospital InK4c-p18 and InK4d-p19, inhibitors of cyclin-dependent kinases CDK4 and CDK6, and uses thereof
US5976799A (en) 1996-03-21 1999-11-02 The Board Of Trustees Of The University Of Arkansas Early detection of ovarian carcinoma using P16 gene products
US5851797A (en) * 1996-06-19 1998-12-22 Regeneron Pharmaceuticals, Inc. Tie ligand-3, methods of making and uses thereof
US5858683A (en) * 1996-08-30 1999-01-12 Matritech, Inc. Methods and compositions for the detection of cervical cancer
WO2000024245A1 (en) * 1998-10-28 2000-05-04 President And Fellows Of Harvard College REGULATION OF TH2 CELL ACTIVITY BY MODULATION OF NFATp AND NFAT4 ACTIVITY

Also Published As

Publication number Publication date
IL140550A0 (en) 2002-02-10
EP1092155B1 (de) 2003-01-02
ES2190820T3 (es) 2003-08-16
RU2217761C2 (ru) 2003-11-27
CA2336153C (en) 2005-12-20
DE19829473C2 (de) 2000-08-10
NO20006681L (no) 2001-02-26
CZ292076B6 (cs) 2003-07-16
HUP0102744A2 (hu) 2001-11-28
AU5848799A (en) 2000-01-24
WO2000001845B1 (de) 2000-04-20
CA2336153A1 (en) 2000-01-13
AU749769B2 (en) 2002-07-04
BRPI9912227B1 (pt) 2013-08-20
EP1092155A2 (de) 2001-04-18
ATE230487T1 (de) 2003-01-15
NO328685B1 (no) 2010-04-26
US6709832B1 (en) 2004-03-23
CN1307681A (zh) 2001-08-08
SK20312000A3 (sk) 2001-10-08
DK1092155T3 (da) 2003-03-24
WO2000001845A2 (de) 2000-01-13
DE19829473A1 (de) 2000-01-13
KR100646193B1 (ko) 2006-11-17
TR200003903T2 (tr) 2001-06-21
PL345407A1 (en) 2001-12-17
WO2000001845A3 (de) 2000-02-17
SK284056B6 (sk) 2004-08-03
PL198623B1 (pl) 2008-07-31
CN1209627C (zh) 2005-07-06
JP3404020B2 (ja) 2003-05-06
CZ20004922A3 (cs) 2001-07-11
US20030152993A1 (en) 2003-08-14
KR20010074632A (ko) 2001-08-04
HK1038609A1 (en) 2002-03-22
JP2002519681A (ja) 2002-07-02
BRPI9912227A (pt) 2001-04-24
DE59903915D1 (de) 2003-02-06
BRPI9912227B8 (pt) 2021-07-06
MXPA00012852A (es) 2003-09-11
NO20006681D0 (no) 2000-12-28

Similar Documents

Publication Publication Date Title
IL140550A (en) Methods for early diagnosis of carcinomas
WO2000005265A3 (en) Anti-crr2 antibodies and methods of use therefor
MY138674A (en) Radiolabeling kit and binding assay
WO1999042090A3 (en) Treating cancer
WO2004037999A3 (en) A34 and a33-like 3 dna, proteins, antibodies thereto and methods of treatment using same
WO1997008318A3 (en) Compounds and methods for treatment and diagnosis of prostate cancer
SE9604815D0 (sv) A metod of diagnosis
FR2816410B1 (fr) Necessaire de detection de la proteine esm-1 et procede de detection mettant en oeuvre ledit necessaire
AU7336400A (en) Diagnostic assay for type 2 heparin-induced thrombocytopenia
EP1179183A4 (en) METHOD FOR IDENTIFYING PRENNEOPLASTIC AND NEOPLASTIC STADIAS IN MAMMALS
CA2366514A1 (en) Diagnostic and therapeutic use of antibodies against the urokinase receptor
GB9609653D0 (en) Method of assay
WO2001007471A3 (en) Cell cycle and proliferation proteins
SE0002835D0 (sv) Method and kit for production of monoclonal antibodies
AU4865997A (en) Monoclonal antibodies against a human act and serine protease complex
NO992531L (no) Fremgangsmåter ved fremstilling av rekombinant protein
AU2002233278A1 (en) Method and use of the cytosolic nadp-dependent malate-decarboxylase isoenzyme for identifying a malignant process, and a suitable test kit
AU9437598A (en) Method and kit for identifying interactions between proteins or peptides
WO1999043829A3 (en) Cell cycle related proteins
IL141858A0 (en) Diagnostic method for detecting disturbances of the pancreas
WO2001006226A3 (de) Verfahren zur bestimmung der proliferationsaktivität von zellen
EP1702984A3 (en) A method for detecting prostate cancer
UA34166A (uk) Спосіб кількісного визначення піпемідієвої кислоти
WO2001004305A3 (en) Human proteins involved in detoxification
UA33566A (uk) Спосіб кількісного визначення ципрофлоксацину

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired